Cargando…
Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?
The blood-brain barrier (BBB) limits the pharmacotherapy of several brain disorders. In addition to the structural and metabolic characteristics of the BBB, the ATP-driven, drug efflux transporter P-glycoprotein (Pgp) is a selective gatekeeper of the BBB; thus, it is a primary hindrance to drug deli...
Autores principales: | Löscher, Wolfgang, Gericke, Birthe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602420/ https://www.ncbi.nlm.nih.gov/pubmed/33066604 http://dx.doi.org/10.3390/pharmaceutics12100966 |
Ejemplares similares
-
Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils
por: Noack, Andreas, et al.
Publicado: (2018) -
A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood–brain barrier models for drug transport studies
por: Gericke, Birthe, et al.
Publicado: (2020) -
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021) -
Advanced Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2022) -
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
por: Georgieva, Julia V., et al.
Publicado: (2014)